この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 1997/4/161 分で読めます
Genzyme Corp.; Premarket Approval of SeprafilmSUPTM Bioresorbable Membrane
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing its approval of the application by Genzyme Corp., Cambridge, MA, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of Seprafilm TM Bioresorbable Membrane. After reviewing the recommendation of the General and Plastic Surgery Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of August 12, 1996, of the approval of the application.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →